The role of peptide and DNA vaccines in myeloid leukemia immunotherapy

<p>Abstract</p> <p>While chemotherapy and targeted therapy are successful in inducing the remission of myeloid leukemia as acute myeloid leukemia (AML) and chronic myeloid leukemia (CML), the disease remains largely incurable. This observation is likely due to the drug resistance o...

Full description

Bibliographic Details
Main Authors: Lin Chen, Li Yangqiu
Format: Article
Language:English
Published: BMC 2013-02-01
Series:Cancer Cell International
Subjects:
Online Access:http://www.cancerci.com/content/13/1/13
_version_ 1828385214070521856
author Lin Chen
Li Yangqiu
author_facet Lin Chen
Li Yangqiu
author_sort Lin Chen
collection DOAJ
description <p>Abstract</p> <p>While chemotherapy and targeted therapy are successful in inducing the remission of myeloid leukemia as acute myeloid leukemia (AML) and chronic myeloid leukemia (CML), the disease remains largely incurable. This observation is likely due to the drug resistance of leukemic cells, which are responsible for disease relapse. Myeloid leukemia vaccines may most likely be beneficial for eradicating minimal residual disease after treatment with chemotherapy or targeted therapy. Several targeted immunotherapies using leukemia vaccines have been heavily investigated in clinical and preclinical trials. This review will focus on peptides and DNA vaccines in the context of myeloid leukemias, and optimal strategies for enhancing the efficacy of vaccines based on myeloid leukemia immunization are also summarized.</p>
first_indexed 2024-12-10T05:16:42Z
format Article
id doaj.art-1b880ade3e6c4fd0855faf6fc0cab0c8
institution Directory Open Access Journal
issn 1475-2867
language English
last_indexed 2024-12-10T05:16:42Z
publishDate 2013-02-01
publisher BMC
record_format Article
series Cancer Cell International
spelling doaj.art-1b880ade3e6c4fd0855faf6fc0cab0c82022-12-22T02:00:56ZengBMCCancer Cell International1475-28672013-02-011311310.1186/1475-2867-13-13The role of peptide and DNA vaccines in myeloid leukemia immunotherapyLin ChenLi Yangqiu<p>Abstract</p> <p>While chemotherapy and targeted therapy are successful in inducing the remission of myeloid leukemia as acute myeloid leukemia (AML) and chronic myeloid leukemia (CML), the disease remains largely incurable. This observation is likely due to the drug resistance of leukemic cells, which are responsible for disease relapse. Myeloid leukemia vaccines may most likely be beneficial for eradicating minimal residual disease after treatment with chemotherapy or targeted therapy. Several targeted immunotherapies using leukemia vaccines have been heavily investigated in clinical and preclinical trials. This review will focus on peptides and DNA vaccines in the context of myeloid leukemias, and optimal strategies for enhancing the efficacy of vaccines based on myeloid leukemia immunization are also summarized.</p>http://www.cancerci.com/content/13/1/13DNA vaccinePeptide vaccineLeukemia-associated antigenMyeloid leukemiaImmunotherapy
spellingShingle Lin Chen
Li Yangqiu
The role of peptide and DNA vaccines in myeloid leukemia immunotherapy
Cancer Cell International
DNA vaccine
Peptide vaccine
Leukemia-associated antigen
Myeloid leukemia
Immunotherapy
title The role of peptide and DNA vaccines in myeloid leukemia immunotherapy
title_full The role of peptide and DNA vaccines in myeloid leukemia immunotherapy
title_fullStr The role of peptide and DNA vaccines in myeloid leukemia immunotherapy
title_full_unstemmed The role of peptide and DNA vaccines in myeloid leukemia immunotherapy
title_short The role of peptide and DNA vaccines in myeloid leukemia immunotherapy
title_sort role of peptide and dna vaccines in myeloid leukemia immunotherapy
topic DNA vaccine
Peptide vaccine
Leukemia-associated antigen
Myeloid leukemia
Immunotherapy
url http://www.cancerci.com/content/13/1/13
work_keys_str_mv AT linchen theroleofpeptideanddnavaccinesinmyeloidleukemiaimmunotherapy
AT liyangqiu theroleofpeptideanddnavaccinesinmyeloidleukemiaimmunotherapy
AT linchen roleofpeptideanddnavaccinesinmyeloidleukemiaimmunotherapy
AT liyangqiu roleofpeptideanddnavaccinesinmyeloidleukemiaimmunotherapy